All practice questions

771 questions

Question 521Question →

Paramedics transport a 68-year-old male to the emergency room due to progressive, profound weakness over the past 24 hours. The patient has a background of ischemic cardiomyopathy and stage IV chronic kidney disease. Current outpatient medications comprise lisinopril, spironolactone, and carvedilol. Initial triage vital signs demonstrate a pulse of 42/min and a blood pressure of 105/60 mmHg. A 12-lead electrocardiogram displays a sine wave pattern with widened QRS complexes and prominently peaked T waves. A point-of-care basic metabolic panel is notable for a potassium concentration of 8.2 mEq/L. Arrange the following pharmacologic therapies in the correct chronological order for the acute management of this presentation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of administration is intravenous calcium gluconate, followed by intravenous regular insulin and 50% dextrose, and finally oral sodium zirconium cyclosilicate.
The correct sequence prioritizes immediate life-saving stabilization over slower, definitive treatments. Intravenous calcium gluconate must be given immediately because it stabilizes the cardiac membrane within 1 to 3 minutes, preventing ventricular fibrillation. Once the heart is stabilized, intravenous regular insulin (with dextrose to prevent hypoglycemia) is given to rapidly shift potassium into cells, which takes 15 to 30 minutes. Finally, oral sodium zirconium cyclosilicate is administered to bind potassium in the gut for permanent excretion from the body, a process that takes hours to days.

Step-by-Step Solution

1
Evaluate the clinical presentation, electrocardiogram, and laboratory values.
Identification of severe hyperkalemia (8.2 mEq/L) with life-threatening cardiac toxicity (sine wave pattern on electrocardiogram).
Recognizing severe hyperkalemia with electrocardiographic changes dictates the immediate need for a step-wise emergency pharmacologic protocol.
2
Prioritize immediate stabilization of the myocardium.
Selection of intravenous calcium gluconate as the first intervention.
Calcium acts within 1 to 3 minutes to antagonize the membrane effects of hyperkalemia, raising the action potential threshold and reducing the imminent risk of ventricular fibrillation.
3
Select an agent to rapidly lower extracellular potassium levels.
Selection of intravenous regular insulin and 50% dextrose as the second intervention.
Insulin temporarily shifts potassium into the cells within 15 to 30 minutes, lowering the serum concentration while definitive removal is prepared.
4
Choose a method for definitive elimination of total body potassium.
Selection of oral sodium zirconium cyclosilicate as the final pharmacologic step.
Cation exchange resins permanently excrete potassium via the gastrointestinal tract but take several hours to become effective, making them the final step in acute management.

Key Concept

The step-wise acute management of severe hyperkalemia with electrocardiographic changes requires immediate myocardial stabilization (calcium), followed by intracellular shifting (insulin/dextrose), and finally total body elimination (cation exchangers or dialysis).
Question 522Question →

A 24-year-old man with type 1 diabetes mellitus is admitted to the intensive care unit for the management of diabetic ketoacidosis precipitated by viral gastroenteritis. He has been receiving aggressive intravenous fluid resuscitation, potassium supplementation, and a continuous regular insulin infusion. Eighteen hours after admission, he is alert, reports feeling hungry, and has no nausea. Current laboratory studies show a serum glucose of 165 mg/dL165 \text{ mg/dL}, a serum bicarbonate of 18 mEq/L18 \text{ mEq/L}, an anion gap of 10 mEq/L10 \text{ mEq/L}, and a venous pH of 7.347.34. The physician determines the patient is ready to transition to a subcutaneous insulin regimen. Arrange the following steps in the correct chronological sequence to safely de-escalate therapy and establish ongoing monitoring.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for transitioning a patient from an intravenous insulin infusion to subcutaneous insulin involves first verifying DKA resolution, followed by administering subcutaneous insulin, overlapping the intravenous infusion for 1 to 2 hours, discontinuing the intravenous infusion, and finally transferring the patient for routine ward monitoring.
The successful transition from intravenous to subcutaneous insulin requires careful sequencing to prevent relapse into diabetic ketoacidosis (DKA). First, objective resolution of DKA (closed anion gap, normalized pH) and clinical stability (ability to eat) must be confirmed. Next, subcutaneous basal and prandial insulin is administered. Because subcutaneous insulin has a delayed onset of action, the continuous intravenous insulin infusion must be maintained for a 1- to 2-hour overlap period. Discontinuing the infusion too early creates a dangerous window of absolute insulin deficiency, leading to rapid lipolysis, ketogenesis, and rebound DKA. Once the overlap period is complete, the intravenous infusion is stopped, and the patient is stepped down to a medical ward with routine glucose monitoring to evaluate the new regimen.

Step-by-Step Solution

1
Verify DKA resolution criteria.
The anion gap is closed (10 mEq/L10 \text{ mEq/L}) and the patient can tolerate a meal.
Ensures physiological stability and safe conditions for step-down therapy.
2
Administer subcutaneous insulin.
Patient receives a dose of basal and prandial insulin.
Initiates long-acting coverage and mealtime glycemic control.
3
Overlap therapies.
Intravenous insulin is maintained for 1 to 2 hours.
Allows adequate time for the subcutaneous insulin to absorb and reach therapeutic systemic levels.
4
Discontinue intravenous insulin.
The continuous infusion is turned off.
Completes the transition safely without causing rebound hyperglycemia.
5
Establish ongoing monitoring.
Glucose checks are scheduled regularly on the medical ward.
Evaluates the adequacy of the new regimen in a lower-acuity setting.

Key Concept

To prevent rebound diabetic ketoacidosis during the transition to subcutaneous insulin, a 1- to 2-hour overlap with the intravenous insulin infusion is mandatory after the first subcutaneous injection.
Question 523Question →

An ambulatory infectious disease clinic evaluates a 45-year-old male patient who recently received a diagnosis of active cavitary pulmonary tuberculosis. His initial sputum acid-fast bacilli (AFB) smear is positive, and rapid molecular testing has confirmed the presence of a pan-susceptible Mycobacterium tuberculosis isolate. As he prepares to commence standard antituberculous pharmacotherapy, the clinical team formulates his longitudinal care plan.

Arrange the following steps representing the appropriate monitoring and treatment evaluation protocol for this patient in the correct chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is to first perform baseline testing, then transition to a two-drug phase at exactly 8 weeks, subsequently review the finalized 8-week culture, extend the continuation phase based on that delayed result, and finally verify treatment completion at 9 months.
The chronological sequence for monitoring and treating cavitary pulmonary tuberculosis follows a strict protocol. Baseline safety labs and visual acuity testing must be obtained before initiating therapy. At exactly 8 weeks, the intensive phase concludes, and therapy is de-escalated to a two-drug continuation phase (assuming pan-susceptibility). Because mycobacterial cultures take several weeks to grow, the finalized results of the 8-week sputum culture are reviewed after the patient has already entered the continuation phase. Upon discovering that this 8-week culture remains positive in a patient with cavitary disease, treatment evaluation protocols require extending the continuation phase from 4 months to 7 months. Finally, clinical resolution is verified at the end of the newly adjusted 9-month course.

Step-by-Step Solution

1
Perform baseline visual acuity testing and a hepatic function panel before initiating the four-drug intensive regimen.
Baseline clinical and safety parameters are established prior to drug exposure.
Monitoring for ethambutol-induced optic neuropathy and medication-induced hepatotoxicity requires baseline comparative values.
2
Transition to a two-drug continuation phase with isoniazid and rifampin upon completing 8 weeks of intensive therapy.
The patient successfully completes the intensive phase and appropriately de-escalates to standard continuation therapy.
The intensive phase is fixed at 8 weeks; de-escalation occurs immediately at this mark when susceptibility is known, without delaying for culture results.
3
Review the finalized 8-week follow-up sputum culture, which demonstrates persistent growth of Mycobacterium tuberculosis.
Delayed microbiologic clearance is officially identified.
Cultures drawn at the 8-week mark take several weeks to finalize and are inherently reviewed during the initial portion of the continuation phase.
4
Extend the planned two-drug continuation phase from 4 months to 7 months due to delayed microbiologic clearance.
The total treatment duration is adjusted from 6 months to 9 months.
Patients with cavitary lung disease and a positive 2-month culture have a substantially higher risk of relapse and require a 7-month continuation phase.
5
Assess for treatment completion and verify clinical resolution at the conclusion of the 9-month total therapy course.
Antituberculous therapy is officially concluded.
Final evaluation ensures all extended doses were successfully taken and the patient is clinically cured prior to discharge from the clinic.

Key Concept

The standard monitoring protocol for cavitary pulmonary tuberculosis involves an 8-week intensive phase, transition to a continuation phase, and subsequent retrospective evaluation of 2-month culture results to determine if the treatment duration must be extended from 6 to 9 months.
Estimated Time:1m 30s
Question 524Question →

A physician is evaluating a 67-year-old male patient who reports a nagging, dry cough persisting for three months. The patient, who has a 45-pack-year history of cigarette smoking, denies hemoptysis, night sweats, or unintentional weight loss. His past medical history includes essential hypertension and mild chronic obstructive pulmonary disease. Auscultation of the lungs reveals globally decreased breath sounds without focal adventitious sounds. An initial posteroanterior and lateral chest radiograph is obtained, revealing an incidental 2.2-cm, irregularly shaped, noncalcified density in the apical region of the right lung.

Arrange the following diagnostic interventions in the correct sequential order to properly work up this patient's pulmonary finding, beginning with the immediate next best step.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct diagnostic sequence is to first review prior imaging, followed by a high-resolution CT of the chest, then a PET scan, and finally a tissue biopsy.
The correct sequence prioritizes minimizing patient risk and resource utilization while sequentially gathering diagnostic data. Reviewing prior imaging can immediately halt a costly workup if the lesion is stable. High-resolution CT provides the necessary anatomic detail to determine if a PET scan is warranted. A PET scan then provides metabolic data and staging information, which ultimately guides the safest and most accurate approach for the final, most invasive step: tissue biopsy.

Step-by-Step Solution

1
Determine the need for further imaging by establishing nodule stability over time.
Review of prior imaging is identified as the first step.
A nodule that has been stable in size for more than two years is almost always benign and requires no further invasive or radiating workup.
2
Characterize the nodule's detailed anatomy if prior imaging is unavailable or shows growth.
High-resolution CT is selected as the second step.
CT delineates morphology, calcification patterns, and regional anatomy with much higher fidelity than plain radiographs.
3
Assess the metabolic activity of the lesion and screen for occult metastases.
FDG-PET scan is selected as the third step.
PET guides staging and identifies the best target for biopsy in high-risk, solid nodules larger than 8 mm.
4
Obtain definitive histopathologic confirmation of the lesion.
Image-guided biopsy is the final step.
Invasive testing should only follow complete non-invasive staging, which dictates the safest and highest-yield approach.

Key Concept

The diagnostic sequencing of a newly discovered solitary pulmonary nodule prioritizes historical data first (prior imaging), followed by detailed anatomic characterization (high-resolution CT), metabolic assessment and staging (PET scan), and finally invasive tissue sampling (biopsy).
Estimated Time:1m 30s
Question 525Question →

A 54-year-old male is preparing for transfer to a skilled nursing facility (SNF) following a prolonged 28-day hospitalization for necrotizing pancreatitis. His hospital course was complicated by critical illness polyneuropathy and newly insulin-dependent diabetes mellitus. The multidisciplinary team has cleared him for discharge, and the case manager has secured an available bed at the SNF for today.

To ensure a safe care transition and adhere to standardized patient handoff protocols, arrange the following transitional care steps in the most appropriate chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with documenting medical stability, followed by medication reconciliation, transmitting the discharge summary, conducting a verbal handover, and finally providing the written plan to the patient upon departure.
Safe and effective transitions of care follow a strict chronological hierarchy to prevent medical errors. The process must begin with the physician documenting that the patient is clinically stable for transfer. Once stability is established, the clinician performs medication reconciliation to determine the exact regimen the patient requires upon transfer. This finalized regimen is incorporated into the electronic discharge summary, which is then transmitted to the receiving facility. After the facility receives the documents, a verbal 'warm handoff' occurs to discuss nuances not fully captured in text. Finally, as the patient physically leaves, the written transition plan is provided to the patient and their proxy to ensure continuity.

Step-by-Step Solution

1
Identify the foundational prerequisite for any care transition.
Documenting medical stability is placed first in the sequence.
Administrative and logistical discharge steps cannot safely commence until the attending physician definitively documents that the patient is medically ready for the transition.
2
Determine the step required to formulate the discharge documentation.
Medication reconciliation is placed second.
A completed medication reconciliation is necessary to generate an accurate discharge summary and to ensure the receiving facility can accommodate the pharmacologic needs.
3
Sequence the provider-to-provider handoff steps.
Transmitting records precedes the verbal handoff.
Standardized transition protocols dictate that written documentation (discharge summary) should be transmitted first, serving as a reference document during the subsequent structured verbal communication (warm handoff).
4
Identify the final step concluding the hospital encounter.
Providing the patient with the physical transition plan is placed last.
Handing over the final physical paperwork coincides with the patient's actual departure, finalizing the acute care episode.

Key Concept

Standardized care transitions require a chronological workflow: establishing medical readiness, finalizing the regimen (medication reconciliation), executing provider-to-provider handoff (written then verbal), and concluding with patient-facing transition logistics.
Question 526Question →

A 27-year-old man is brought to the emergency department after a high-speed motorcycle collision. On arrival, he is obtunded, and his airway is immediately secured via endotracheal intubation. Vital signs are temperature 34.8°C (94.6°F), heart rate 145/min, and blood pressure 65/40 mmHg. Breath sounds are equal bilaterally, and a portable chest radiograph is unremarkable. The pelvis is mechanically stable. An extended focused assessment with sonography for trauma (eFAST) scan shows a large amount of free fluid in the hepatorenal and splenorenal spaces, with no pericardial effusion. A massive transfusion protocol is initiated.

Arrange the following surgical and procedural interventions in the most appropriate chronological order for this patient's definitive management.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for a damage control laparotomy in a hemodynamically unstable trauma patient is: 1) Emergency laparotomy, 2) Four-quadrant packing, 3) Sequential unpacking and hemostasis, 4) Temporary abdominal closure, and 5) ICU transfer for physiologic resuscitation.
The correct sequence outlines the standard protocol for Damage Control Laparotomy in severe trauma. The primary goal of this intervention is physiologic survival rather than definitive anatomical repair. The patient must first undergo an immediate laparotomy to access the bleeding. This is followed immediately by four-quadrant packing to halt hemorrhage and allow for initial resuscitation. Once circulating volume is partially restored, the surgeon sequentially unpacks to definitively control identified bleeding sources (e.g., vessel ligation, splenectomy, or bowel stapling). Because the patient is hypothermic and in hemorrhagic shock, the procedure is purposefully abbreviated by leaving the abdomen open with a temporary negative-pressure closure device. Finally, the patient is moved to the ICU to correct the lethal triad (hypothermia, acidosis, and coagulopathy) before returning for definitive surgical reconstruction.

Step-by-Step Solution

1
Perform an immediate midline laparotomy
Rapid access to the abdominal cavity and evacuation of gross hemorrhage
To immediately address life-threatening intra-abdominal hemorrhage identified on the eFAST scan in a hemodynamically unstable patient.
2
Pack all four abdominal quadrants
Temporary tamponade of diffuse bleeding sources
To quickly halt blood loss and allow the anesthesia team critical time to transfuse blood products and stabilize the patient's hemodynamics.
3
Sequentially remove the sponges
Targeted identification and surgical control of specific injuries
To systematically expose and repair organ injuries or ligate bleeding vessels without releasing the life-saving tamponade on all bleeding sites simultaneously.
4
Apply a temporary negative-pressure abdominal closure device
Abdomen is left open but protected from the external environment
To prevent abdominal compartment syndrome and minimize surgical time in a patient suffering from the lethal triad.
5
Transfer to the intensive care unit
Ongoing physiologic resuscitation and monitoring
To actively warm the patient, correct acidosis, and reverse coagulopathy prior to returning to the operating room for definitive repairs 24 to 48 hours later.

Key Concept

Damage Control Laparotomy Sequence
Question 527Question →

A 68-year-old retired teacher is admitted to the cardiac telemetry unit for the elective initiation of dofetilide to maintain normal sinus rhythm after a recent electrical cardioversion for symptomatic atrial fibrillation. He has a history of hypertension and ischemic cardiomyopathy. His home medications include lisinopril, metoprolol succinate, and apixaban. His vital signs are stable, and the physical examination is unremarkable. The care team is planning the mandatory safety protocol for initiating this antiarrhythmic therapy.

Arrange the following clinical steps in the correct chronological sequence for the initiation, monitoring, and evaluation of dofetilide therapy in this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is to first establish baseline parameters, administer the initial dose, perform peak ECG monitoring at 2 to 3 hours, adjust the dose if QTc prolongation is observed, and finally complete the mandatory 3-day inpatient monitoring period.
The initiation of dofetilide requires mandatory in-hospital monitoring due to its profound risk of dose-dependent QT prolongation and torsades de pointes. The standard protocol requires obtaining a baseline ECG and renal function to calculate the starting dose, as the drug is renally cleared. After the first dose is administered, the peak effect occurs at 2 to 3 hours, mandating an ECG at this exact time to evaluate repolarization changes. If the QTc interval increases by >15% or exceeds 500 ms at peak, a protocolized dose reduction is required. Finally, because steady-state and peak risks stabilize over several days, the patient must remain on continuous telemetry for a minimum of 3 days or 6 doses (whichever is greater) before safe transition to outpatient management.

Step-by-Step Solution

1
Establish safety baselines
Baseline QTc and creatinine clearance are determined.
Dofetilide is contraindicated if baseline QTc is elevated, and the initial dose must be strictly adjusted for renal function.
2
Administer first dose
Patient receives the renally-adjusted dose.
Initiates the therapeutic trial under strictly monitored inpatient conditions.
3
Monitor at peak concentration
An ECG is obtained 2 to 3 hours post-dose.
This is the time of maximal drug concentration and highest risk for fatal arrhythmias like torsades de pointes.
4
Evaluate and adjust treatment
Dose is reduced or discontinued if QTc is excessively prolonged.
Ensures real-time safety adaptation to the patient's individual pharmacodynamic response.
5
Complete monitoring period
Patient is monitored for at least 3 days.
Allows the drug to reach steady state safely before outpatient transition.

Key Concept

The initiation of dofetilide requires a strict inpatient protocol consisting of baseline assessment, renal dosing, peak ECG monitoring at 2-3 hours post-dose to evaluate for repolarization abnormalities, algorithmic dose adjustment, and a mandatory minimum 3-day telemetry monitoring period.
Question 528Question →

A patient is currently receiving treatment in the cardiovascular step-down unit for a massive pulmonary embolism diagnosed three days ago. She was initially started on an unfractionated heparin infusion. Today, her daily laboratory monitoring reveals a precipitous drop in her platelet count. She has also developed a new, painful, swollen right calf.

Hospital DayPlatelet Count
Day 1 (Admission)240,000/μL240,000/\mu L
Day 2215,000/μL215,000/\mu L
Day 3160,000/μL160,000/\mu L
Day 4 (Today)95,000/μL95,000/\mu L

A serotonin release assay is sent, and a clinical diagnosis of heparin-induced thrombocytopenia (HIT) with a new deep vein thrombosis is suspected.

Arrange the following management and monitoring steps in the correct chronological sequence to appropriately treat this patient's condition and safely transition her to long-term oral anticoagulation with warfarin.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is to first discontinue heparin, then initiate a direct thrombin inhibitor, monitor platelets until they recover, initiate overlapping warfarin, and finally discontinue the direct thrombin inhibitor once the INR is therapeutic.
The standard of care for heparin-induced thrombocytopenia (HIT) involves immediately discontinuing all heparin products and initiating a non-heparin anticoagulant like argatroban. Transitioning to long-term oral warfarin requires strict monitoring: warfarin cannot be started until the platelet count recovers to at least 150,000/μL150,000/\mu L. Once started, warfarin must be overlapped with the parenteral anticoagulant for at least 5 days and until the INR is strictly therapeutic (2.02.0-3.03.0) for 24-48 hours before the parenteral agent can be safely discontinued.

Step-by-Step Solution

1
Discontinue unfractionated heparin
Halts further immune complex formation
Heparin is the offending agent causing antibody-mediated platelet activation.
2
Start argatroban
Provides immediate alternative anticoagulation
Patients with heparin-induced thrombocytopenia have a high risk of new or progressive thrombosis and require ongoing systemic anticoagulation.
3
Monitor platelet counts
Confirms recovery from the acute consumptive phase
Platelet recovery (typically ≥150,000/μL\geq 150,000/\mu L) indicates that the acute prothrombotic state is resolving.
4
Initiate warfarin
Begins transition to long-term oral therapy
Warfarin can now be safely introduced without the high risk of venous limb gangrene caused by early protein C depletion.
5
Monitor INR and discontinue argatroban
Completes the transition to monotherapy
Overlap ensures continuous anticoagulation until warfarin fully inhibits vitamin K-dependent clotting factors.

Key Concept

In patients with heparin-induced thrombocytopenia, warfarin should only be initiated after platelets recover to ≥150,000/μL\geq 150,000/\mu L, followed by an overlap period with a non-heparin parenteral anticoagulant until the INR is therapeutic.
Question 529Question →

A 73-year-old retired pilot arrives at the emergency department accompanied by his wife, complaining of a sudden, agonizing pain across his entire abdomen that started approximately 90 minutes ago. He has a known medical history of heart failure with preserved ejection fraction and paroxysmal atrial fibrillation, for which he has been poorly compliant with his prescribed anticoagulant therapy. Shortly before leaving his house, he passed a large amount of dark red blood from his rectum. Vital signs show a temperature of 37.2°C (99.0°F), blood pressure of 162/94 mmHg, heart rate of 122/min with an irregularly irregular rhythm, and respiratory rate of 22/min. On physical examination, the patient appears in severe distress, writhing on the stretcher. However, his abdomen is soft, non-distended, and only mildly tender to deep palpation without any rebound tenderness, guarding, or rigidity. Bowel sounds are hypoactive. Arrange the following differential diagnoses from the MOST likely (highest pre-test probability) to the LEAST likely (lowest pre-test probability) based on this patient's clinical presentation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct order from most likely to least likely is: Acute mesenteric ischemia, Ischemic colitis, Acute pancreatitis, Perforated peptic ulcer.
The correct sequence prioritizes the diagnoses based on the congruence between the patient's risk factors (atrial fibrillation without anticoagulation), symptoms (sudden agonizing pain, bloody stool), and physical exam findings (pain out of proportion to a benign exam). Acute mesenteric ischemia perfectly aligns with an embolic event to the gut. Ischemic colitis is a vascular phenomenon but is typically less acute and less severe. Acute pancreatitis and perforated ulcer lack the 'pain out of proportion' feature and do not typically present with hematochezia.

Step-by-Step Solution

1
Analyze the patient's primary symptoms and vital signs.
The patient has sudden, severe abdominal pain and bloody diarrhea, accompanied by tachycardia and an irregularly irregular pulse.
Identifying the chief complaint and vital sign abnormalities provides the physiological context for the differential.
2
Correlate symptoms with physical examination findings.
The patient is writhing in agony, yet the abdomen is soft and non-peritonitic. This confirms 'pain out of proportion to physical exam findings.'
The discrepancy between subjective pain and objective abdominal findings is a classic hallmark of early bowel ischemia.
3
Evaluate risk factors and establish the most likely etiology.
The poorly anticoagulated atrial fibrillation strongly suggests a cardioembolic source, pointing to superior mesenteric artery (SMA) embolism as the cause of acute mesenteric ischemia.
Matching risk factors with the clinical presentation establishes the highest pre-test probability.
4
Rank the remaining differentials based on clinical divergence.
Ischemic colitis is ranked second as it shares vascular pathology but is less acute. Pancreatitis is third (lacks the correct pain pattern and peritonitis). Perforated ulcer is last (presents with a rigid, peritonitic abdomen, not a soft one).
Systematically ruling out other diagnoses based on hallmark findings ensures an accurate hierarchical differential.

Key Concept

In patients with atrial fibrillation and severe abdominal pain out of proportion to physical exam findings, acute mesenteric ischemia is the most likely diagnosis. Recognizing this classic presentation allows for accurate prioritization of differentials before progression to bowel necrosis and peritonitis.
Question 530Question →

A 78-year-old man is being prepared for discharge after a 12-day hospitalization for urosepsis. Upon admission, his temperature was 38.9°C (102.0°F), blood pressure was 85/50 mm Hg, and serum creatinine was 3.2 mg/dL. He responded well to intravenous fluids and antibiotics; current vitals are temperature 37.1°C (98.8°F), blood pressure 122/76 mm Hg, and heart rate 78/min. His serum creatinine has improved to 1.8 mg/dL. Despite medical stabilization, his functional status has declined, requiring the assistance of two people for transfers. Furthermore, his cognitive status continues to fluctuate with new-onset delirium, and a formal assessment reveals he currently lacks medical decision-making capacity. The care team is initiating the discharge process. Arrange the following critical steps in this patient's transition of care in the most appropriate chronological order to ensure a safe, legally sound, and comprehensive disposition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Identify the surrogate decision-maker, 2) Determine the post-acute care setting, 3) Perform medication reconciliation, 4) Finalize the discharge summary, and 5) Execute a verbal provider-to-provider handoff.
A safe and legally sound transition of care for an incapacitated patient follows a structured sequence: First, the legally authorized surrogate must be identified to provide consent. Second, the appropriate care setting is determined collaboratively with the surrogate. Third, medication reconciliation is performed to tailor the pharmacologic plan to the patient's current physiologic state and the new setting. Fourth, these plans are formalized into a comprehensive written discharge summary. Finally, a synchronous verbal handoff is conducted to ensure closed-loop communication with the receiving providers.

Step-by-Step Solution

1
Assess the patient's capacity and legal framework.
Identification of the surrogate decision-maker.
The patient's delirium impairs capacity, meaning legal consent for discharge planning must come from the authorized surrogate.
2
Collaborate on disposition planning.
Determination of the post-acute care setting.
The surrogate and multidisciplinary team must agree on the discharge location based on the patient's severe functional decline.
3
Optimize medical therapy for discharge.
Comprehensive medication reconciliation.
Medications must be adjusted for the patient's improving but still impaired renal function and the formulary capabilities of the receiving setting before finalizing discharge orders.
4
Document the transition plan.
Finalization of the discharge summary.
A comprehensive written document detailing the hospital course, reconciled medications, and pending tests is essential for continuity of care.
5
Communicate the plan to the receiving team.
Synchronous verbal handoff.
Direct communication resolves ambiguities and ensures the receiving facility is fully prepared for the transfer.

Key Concept

Standardized transition of care protocol for incapacitated patients
Estimated Time:1m 30s
Question 531Question →

A 62-year-old man is recovering on the general medical floor after a three-week hospitalization for severe sepsis secondary to ascending cholangitis. He initially required vasopressor support and mechanical ventilation but is now hemodynamically stable, afebrile, and breathing comfortably on room air. Due to significant intensive care unit-acquired weakness, he cannot perform basic activities of daily living independently. The primary internal medicine team determines that he requires transfer to a skilled nursing facility (SNF) for comprehensive physical and occupational therapy prior to returning home.

Arrange the following essential steps of this care transition process in the most appropriate chronological sequence to ensure patient safety and minimize the risk of readmission.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Document medical stability and specific needs, followed by collaborating to secure authorization and a bed, then performing final medication reconciliation and transfer orders, and finally conducting a structured verbal handoff while transmitting the discharge summary.
Safe and effective care transitions require a standardized, sequential approach to minimize errors. The process must begin with the physician establishing medical readiness and documenting specific post-acute needs. This clinical documentation is strictly required by case management to secure insurance authorization and confirm bed placement at an appropriate facility. Only after the specific destination is confirmed should the final medication reconciliation and transfer orders be generated, ensuring the regimen is accurate and actionable for that specific SNF. Finally, a structured verbal handoff and the transmission of the written discharge summary occur just prior to physical transfer to ensure the receiving team has the most up-to-date, finalized information.

Step-by-Step Solution

1
Determine readiness and specific needs.
The physician documents that the patient is medically stable but requires SNF-level physical therapy for ICU-acquired weakness.
Clear clinical documentation is the prerequisite for initiating the disposition planning process.
2
Secure facility placement and authorization.
Case management uses the documentation to obtain payer authorization and reserves a bed at an appropriate SNF.
Transfer orders cannot be finalized until a specific receiving destination is confirmed and authorized.
3
Finalize the medical transition plan.
The physician performs medication reconciliation, stopping acute hospital medications (e.g., DVT prophylaxis injections if transitioning to oral) and writes the formal transfer orders.
The receiving facility requires an accurate, finalized set of orders to safely admit the patient and administer medications immediately upon arrival.
4
Execute the clinical handoff.
The primary team provides a structured verbal report to the SNF staff and transmits the comprehensive discharge summary.
Direct communication of the finalized plan prevents continuity of care errors during the vulnerable transition period.

Key Concept

Standardized Care Transitions and Disposition Planning
Estimated Time:1m 15s
Question 532Question →

An established 38-year-old female patient presents for follow-up regarding resistant hypertension. She reports experiencing profound muscle cramps and episodic weakness over the last month. Clinical assessment reveals a blood pressure of 168/102 mm Hg, which has remained uncontrolled despite strict adherence to maximum tolerated doses of lisinopril, amlodipine, and hydrochlorothiazide. A basic metabolic panel highlights a serum potassium level of 2.8 mEq/L. Suspecting primary hyperaldosteronism, the physician tapers her interfering medications, transitions her to doxazosin, and normalizes her potassium. Arrange the subsequent diagnostic investigations in the correct chronological order, proceeding from the initial diagnostic step to the definitive pre-surgical assessment.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Measurement of plasma aldosterone concentration and plasma renin activity -> Confirmatory sodium suppression test -> High-resolution CT of the adrenal glands -> Adrenal venous sampling.
The correct diagnostic sequence for primary hyperaldosteronism begins with biochemical screening, followed by biochemical confirmation, then anatomical localization, and finally functional lateralization. First, the ratio of plasma aldosterone concentration to plasma renin activity (PAC/PRA) is measured as a highly sensitive screening tool. If elevated, the diagnosis is confirmed by demonstrating inappropriate autonomous aldosterone secretion during a sodium suppression test (such as an intravenous saline infusion). Once the biochemical diagnosis is secure, an adrenal protocol CT scan is performed to visualize the adrenal glands, rule out large suspected carcinomas, and map the venous anatomy. Finally, because non-functioning adrenal nodules are common and imaging alone cannot definitively prove which gland is hypersecreting, adrenal venous sampling (AVS) is performed to differentiate between a unilateral aldosterone-producing adenoma and bilateral adrenal hyperplasia.

Step-by-Step Solution

1
Perform initial biochemical screening.
Measurement of the plasma aldosterone concentration to plasma renin activity (PAC/PRA) ratio.
A high PAC/PRA ratio is highly sensitive for detecting autonomous aldosterone production and serves as the standard first-line screen.
2
Execute biochemical confirmation.
Confirmatory sodium suppression test (e.g., intravenous saline infusion or oral sodium loading).
Screening tests can yield false positives; therefore, failure to suppress aldosterone levels in the face of a high sodium load confirms the diagnosis.
3
Obtain initial anatomical localization.
High-resolution computed tomography (CT) of the adrenal glands.
Imaging is required to exclude large malignant masses and to provide an anatomical roadmap of the adrenal veins for the interventional radiologist.
4
Perform functional lateralization.
Adrenal venous sampling (AVS).
Imaging cannot distinguish between a functional unilateral adenoma and a non-functioning incidentaloma with concurrent bilateral hyperplasia; AVS is required to prove lateralization before surgery.

Key Concept

The diagnostic workup for primary hyperaldosteronism follows a strict sequential algorithm: Screen (PAC/PRA) -> Confirm (Sodium suppression) -> Localize (Adrenal CT) -> Lateralize (Adrenal Venous Sampling).
Estimated Time:1m 30s
Question 533Question →

A 6262-year-old man with a 1010-year history of type 2 diabetes mellitus returns to the clinic for a routine follow-up. His current medication regimen includes maximum tolerated doses of metformin, empagliflozin, and a glucagon-like peptide-1 (GLP-1) receptor agonist. His hemoglobin A1c today is 9.5%9.5\%, and his home fasting blood glucose levels consistently range between 180180 and 220 mg/dL220\text{ mg/dL}. The physician and patient agree that initiating insulin therapy is the most appropriate next step. Arrange the following steps in the correct chronological sequence for intensifying and monitoring this patient's insulin therapy over the coming months according to standard diabetes care guidelines.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: (1) Initiate a once-daily basal insulin injection, (2) Titrate the basal insulin dose based on fasting blood glucose monitoring, (3) Assess postprandial blood glucose levels if HbA1c remains unmet, and (4) Add a single injection of rapid-acting prandial insulin before the largest meal.
The American Diabetes Association (ADA) recommends a stepwise approach to insulin intensification in type 2 diabetes. When oral agents and GLP-1 receptor agonists are insufficient, the first step is to initiate basal insulin. The basal dose is then systematically titrated based on fasting blood glucose readings until the fasting target is achieved. If the fasting target is met but the hemoglobin A1c remains above the individualized goal, this indicates that postprandial excursions are driving the persistent hyperglycemia. Therefore, the next step in treatment evaluation is to monitor postprandial blood glucose levels. Once postprandial hyperglycemia is confirmed, the treatment is further intensified by adding a dose of rapid-acting prandial insulin, usually starting with the largest or most carbohydrate-heavy meal of the day.

Step-by-Step Solution

1
Address the high fasting blood glucose.
Initiate basal insulin.
Basal insulin targets fasting hyperglycemia, which is the primary driver of HbA1c elevation in this range.
2
Evaluate and optimize the initial therapy.
Titrate basal insulin.
The initial basal dose must be adjusted upward until the fasting blood glucose reaches the therapeutic target (typically 8080 to 130 mg/dL130\text{ mg/dL}).
3
Investigate persistent overall hyperglycemia (elevated HbA1c) despite achieving fasting targets.
Measure postprandial blood glucose.
If fasting levels are normal but HbA1c is high, postprandial excursions are the likely cause and must be documented.
4
Intensify therapy to address postprandial excursions.
Add rapid-acting prandial insulin.
A single dose of prandial insulin before the largest meal directly mitigates the identified postprandial hyperglycemia, completing the stepwise approach.

Key Concept

The stepwise approach to initiating, monitoring, and intensifying insulin therapy in type 2 diabetes mellitus.
Question 534Question →

A 62-year-old woman is brought to the emergency department by her family due to a 2-day history of progressively worsening severe right-sided abdominal pain, high fever, and new-onset confusion. Her past medical history is significant for hypertension and hyperlipidemia. On arrival, her temperature is 39.4∘C39.4^\circ\text{C} (102.9∘F102.9^\circ\text{F}), blood pressure is 84/52 mm Hg84/52\text{ mm Hg}, heart rate is 122/min122/\text{min}, and respiratory rate is 24/min24/\text{min}. Physical examination reveals marked scleral icterus, dry mucous membranes, and significant tenderness to palpation in the right upper quadrant without rebound or guarding. The patient is lethargic and disoriented to time and place. Laboratory studies show a leukocyte count of 18,500/mm318,500/\text{mm}^3, a total bilirubin of 6.2 mg/dL6.2\text{ mg/dL}, direct bilirubin of 4.8 mg/dL4.8\text{ mg/dL}, and an alkaline phosphatase of 450 U/L450\text{ U/L}. Arrange the following management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: initial stabilization with IV fluids and antibiotics, followed by a right upper quadrant ultrasound, then urgent ERCP, and finally an elective laparoscopic cholecystectomy.
The patient presents with classic signs of Reynolds pentad (fever, jaundice, right upper quadrant pain, hypotension, and altered mental status), indicating severe acute ascending cholangitis complicated by septic shock. The standard sequence of management for such a surgical emergency begins with immediate patient stabilization, which includes aggressive intravenous fluid resuscitation and broad-spectrum antibiotics to address the septic shock. Once stabilizing measures are initiated, a right upper quadrant ultrasound must be obtained to confirm the diagnosis by visualizing common bile duct dilation and potential choledocholithiasis. Following diagnostic confirmation, urgent biliary decompression is required because medical management alone is inadequate for severe suppurative cholangitis; ERCP is the procedure of choice. Finally, after the patient is stabilized and recovers from the acute illness, an elective laparoscopic cholecystectomy should be performed prior to hospital discharge to prevent recurrent biliary events.

Step-by-Step Solution

1
Recognize the clinical presentation of severe acute cholangitis.
The patient exhibits Reynolds pentad (fever, right upper quadrant pain, jaundice, hypotension, altered mental status).
Identifying the severity of the condition dictates the urgency of intervention.
2
Prioritize initial hemodynamic stabilization.
Administer isotonic crystalloids and broad-spectrum intravenous antibiotics.
The patient is in septic shock; delaying resuscitation can lead to multiorgan failure and death.
3
Confirm the diagnosis with noninvasive imaging.
Obtain a right upper quadrant abdominal ultrasound.
Ultrasound quickly and safely confirms common bile duct dilation and helps rule out other acute abdominal pathologies.
4
Decompress the biliary tree urgently.
Perform urgent endoscopic retrograde cholangiopancreatography (ERCP).
In severe (suppurative) cholangitis, medical management alone is insufficient, and urgent purulent drainage via ERCP is required.
5
Plan definitive surgical management.
Perform a laparoscopic cholecystectomy.
After the acute episode resolves, removing the source of the gallstones prevents future life-threatening occurrences.

Key Concept

The management of severe acute ascending cholangitis requires sequential steps: immediate hemodynamic stabilization, noninvasive diagnostic confirmation, urgent biliary decompression, and subsequent definitive surgical care.
Question 535Question →

A 78-year-old woman with a history of congestive heart failure and chronic kidney disease is hospitalized for a severe heart failure exacerbation. After a 5-day stay, she has reached clinical stability. The interdisciplinary team is preparing her for transition to a skilled nursing facility (SNF) for subacute rehabilitation. To ensure patient safety, prevent medication errors, and minimize readmission risk, arrange the following steps of the transitions-of-care pathway in the correct chronological sequence according to standard safe discharge practices.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The chronological sequence is: 1) Needs assessment to determine disposition, 2) Medication reconciliation to finalize the regimen, 3) Patient/caregiver education via teach-back, 4) Transmission of the discharge summary to receiving clinicians, and 5) Post-transition telephone outreach.
A safe and effective transition of care pathway follows a logical chronological progression designed to eliminate gaps in patient safety. Early assessment of functional and social needs determines the appropriate disposition setting (e.g., SNF) well before the actual discharge date. As the patient approaches clinical stability, a rigorous medication reconciliation must be performed to finalize the discharge regimen and prevent polypharmacy or omissions. Only after this regimen is finalized can meaningful, teach-back education be provided to the patient and family. At the time of physical transfer, a comprehensive discharge summary must be communicated to the receiving clinicians to ensure immediate continuity of care. Finally, a post-transition outreach call is conducted within 48-72 hours to ensure the plan is being executed safely and to intercept early signs of clinical deterioration.

Step-by-Step Solution

1
Assess functional status and post-discharge needs.
Determination of the safest disposition setting (SNF).
Disposition planning must begin early in the hospital course to allow adequate time for facility coordination and insurance approval.
2
Complete discharge medication reconciliation.
Generation of an accurate, finalized list of post-discharge medications.
Resolving discrepancies between home medications and hospital therapies prevents adverse drug events and is required before counseling the patient.
3
Provide teach-back education to the patient and family.
Confirmation of patient understanding regarding medications and warning signs.
Patients must understand their finalized care plan before leaving the hospital to prevent early readmissions.
4
Transmit the discharge summary and records to the SNF.
Seamless transfer of medical information to the accepting clinicians.
Receiving providers require immediate access to the reconciled medication list and hospital course summary to safely assume care upon the patient's arrival.
5
Execute post-transition telephone outreach.
Verification of clinical stability and adherence in the new setting.
A systematic follow-up within 48-72 hours identifies gaps in care, such as missing medications or early symptom recurrence, mitigating the risk of readmission.

Key Concept

Safe transitions of care follow a structured pathway: early disposition assessment, formalized medication reconciliation, teach-back patient education, standardized clinician-to-clinician handoff, and early post-discharge follow-up.
Estimated Time:1m 30s
Question 536Question →

A 52-year-old woman is hospitalized for a massive pulmonary embolism and treated with a continuous unfractionated heparin infusion. On hospital day 66, her platelet count decreases from an admission baseline of 260,000/mm3260,000/\text{mm}^3 to 85,000/mm385,000/\text{mm}^3. She subsequently reports acute left lower extremity pain, and a duplex ultrasound confirms a new deep vein thrombosis. Her clinical presentation yields a 4T score indicating a high probability of heparin-induced thrombocytopenia (HIT). Arrange the following therapeutic management and monitoring steps in the correct chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first discontinue heparin, immediately start a non-heparin anticoagulant (argatroban), monitor platelets until they recover above 150,000, then initiate warfarin, and finally stop argatroban after the INR has been therapeutic for 48 hours.
The management of HIT requires a strict multi-step de-escalation and transition protocol. All heparin must be stopped immediately to break the cycle of PF4-antibody complex formation. Because the patient is actively thrombosing, an alternative anticoagulant (e.g., argatroban, bivalirudin, or fondaparinux) must be started empirically without waiting for lab confirmation. The transition to long-term warfarin requires careful monitoring: platelets must first recover to baseline or ≥150,000/mm3\geq 150,000/\text{mm}^3 to avoid warfarin-induced skin necrosis and venous limb gangrene. Once started, warfarin must overlap with the parenteral anticoagulant for at least 55 days, and the parenteral agent is only discontinued when the INR has been therapeutic for 4848 hours.

Step-by-Step Solution

1
Discontinue heparin
Halts the ongoing formation of heparin-PF4 complexes.
Continuing heparin worsens the immune response and exacerbates thrombosis.
2
Initiate argatroban
Provides immediate, safe anticoagulation.
Patients with HIT are highly prothrombotic and require continuous anticoagulation while avoiding all heparin products.
3
Monitor platelet recovery
Confirms the HIT process is resolving.
Wait for platelets to reach at least 150,000/mm3150,000/\text{mm}^3 to ensure the hypercoagulable state is stabilizing.
4
Initiate warfarin
Begins the transition to long-term oral anticoagulation.
Starting warfarin too early (before platelet recovery) causes a precipitous drop in Protein C, paradoxically worsening hypercoagulability and risking venous limb gangrene.
5
Overlap and discontinue argatroban
Ensures uninterrupted protection against thrombosis.
Warfarin takes several days to achieve full antithrombotic effect. Argatroban must be continued until the INR is therapeutic (2.0−3.02.0-3.0) for at least 4848 hours.

Key Concept

Management and monitoring sequence of Heparin-Induced Thrombocytopenia (HIT)
Estimated Time:1m 30s
Question 537Question →

A 2222-year-old woman is brought to the emergency department 22 hours after intentionally ingesting a large, unknown quantity of acetaminophen tablets. She is currently asymptomatic, with normal vital signs and an unremarkable physical examination. Arrange the following steps in the most appropriate chronological sequence for monitoring, evaluating, and managing this patient's overdose according to standard medical protocols.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first wait 44 hours to obtain an interpretable serum level, plot this level on the Rumack-Matthew nomogram, initiate NN-acetylcysteine if the level is above the treatment line, monitor liver chemistries serially during treatment, and finally discontinue the antidote once criteria for resolution are met.
The standard management protocol for acute acetaminophen ingestion requires establishing an accurate peak serum level to guide antidote therapy. Because acetaminophen absorption can be delayed, levels drawn before 44 hours post-ingestion are uninterpretable. Once a valid level is obtained at or after 44 hours, it must be plotted on the Rumack-Matthew nomogram to stratify the patient's risk of hepatotoxicity. If the value falls on or above the treatment line, NN-acetylcysteine (NAC) therapy is initiated to replenish hepatic glutathione stores. While on NAC, the patient requires ongoing monitoring of liver function tests (AST, ALT), coagulation (PT/INR), and renal function to evaluate for subacute hepatic injury. Finally, the treatment is evaluated for discontinuation; NAC can be safely stopped only when the patient is asymptomatic, liver enzymes are normalizing, and the serum acetaminophen level is undetectable.

Step-by-Step Solution

1
Delay initial serum level until 44 hours post-ingestion
Obtains an accurate reflection of peak absorption
Levels drawn before 44 hours are uninterpretable on the nomogram due to ongoing drug absorption.
2
Plot level on the Rumack-Matthew nomogram
Risk stratification for hepatotoxicity
Determines if the patient's toxic burden warrants antidote therapy.
3
Initiate NN-acetylcysteine (NAC)
Prevents accumulation of the toxic NAPQI metabolite
Provides a glutathione substitute to detoxify the liver if the nomogram indicates high risk.
4
Monitor serial LFTs and coagulation studies
Tracks the evolution of hepatic injury
Detects subacute hepatotoxicity that may develop despite NAC and guides ongoing treatment.
5
Discontinue NAC based on clinical and laboratory criteria
Safe conclusion of therapy
Ensures the toxic threat has completely resolved (undetectable acetaminophen and improving LFTs) before stopping the antidote.

Key Concept

Monitoring and evaluating treatment in acute acetaminophen overdose relies on delaying initial levels until peak absorption at 44 hours, using the Rumack-Matthew nomogram for risk stratification, and guiding the discontinuation of NN-acetylcysteine with serial liver function monitoring.
Estimated Time:1m 30s
Question 538Question →

A 58-year-old man with a history of stage 4 chronic kidney disease and heart failure is brought to the emergency department due to profound generalized muscle weakness and palpitations that began earlier today. His medications include lisinopril and newly prescribed spironolactone. His heart rate is 54/min, and blood pressure is 112/68 mmHg. An electrocardiogram reveals widened QRS complexes merging with tall, peaked T waves in a "sine wave" pattern. A point-of-care basic metabolic panel shows a serum potassium level of 8.4 mEq/L.

Arrange the following pharmacologic interventions in the most appropriate chronological sequence for the acute management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of administration is: 1) Intravenous calcium gluconate, 2) Intravenous regular insulin and 50% dextrose, 3) Oral sodium zirconium cyclosilicate.
The fundamental algorithm for severe hyperkalemia with electrocardiographic changes dictates a strict temporal sequence based on the onset of action of each pharmacologic agent. First, myocardial cell membranes must be stabilized to prevent lethal arrhythmias, which is achieved rapidly (1-3 minutes) with intravenous calcium gluconate. Second, potassium must be temporarily redistributed into the intracellular compartment using intravenous regular insulin (accompanied by dextrose to prevent hypoglycemia); this process takes 15-30 minutes. Finally, total body potassium must be definitively reduced using gastrointestinal potassium binders such as sodium zirconium cyclosilicate, which have an onset of several hours. Proceeding in any other order leaves the patient vulnerable to sudden cardiac death.

Step-by-Step Solution

1
Identify the life-threatening emergency.
The patient has severe hyperkalemia (8.4 mEq/L) with critical ECG changes (widened QRS, sine wave pattern).
Recognizing sine wave morphology indicates impending cardiac arrest, necessitating immediate step-wise intervention.
2
Prioritize myocardial stabilization.
Select intravenous calcium gluconate as the immediate first intervention.
Calcium directly antagonizes the membrane actions of hyperkalemia. It restores the resting membrane potential difference, taking effect in 1-3 minutes to prevent fatal arrhythmias.
3
Initiate temporary potassium shifting.
Select intravenous regular insulin (with dextrose to prevent hypoglycemia) as the second intervention.
Once the heart is temporarily protected, serum potassium must be rapidly lowered. Insulin drives potassium into cells via Na+/K+-ATPase activation, acting within 15-30 minutes.
4
Establish definitive potassium removal.
Select oral sodium zirconium cyclosilicate as the final pharmacologic step in this sequence.
Calcium and insulin are temporary measures. A potassium binder removes total body potassium through the gastrointestinal tract, providing definitive but slower (hours) treatment.

Key Concept

The sequential management of severe hyperkalemia involves three distinct phases: immediate myocardial stabilization (calcium), rapid intracellular shifting (insulin/glucose), and definitive total body removal (cation exchange resins or loop diuretics).
Question 539Question →

A 26-year-old man with a known history of ulcerative colitis is admitted to the hospital with an acute flare. He reports 10 to 12 bloody bowel movements daily and severe lower abdominal pain. His temperature is 38.4∘C38.4^\circ\text{C} (101.1∘F101.1^\circ\text{F}), blood pressure is 110/70 mm Hg110/70 \text{ mm Hg}, and heart rate is 118/min118/min. Laboratory results show a hemoglobin of 9.8 g/dL9.8 \text{ g/dL}, leukocyte count of 14,000/μL14,000/\mu\text{L}, and C-reactive protein (CRP) of 90 mg/L90 \text{ mg/L}. A diagnosis of acute severe ulcerative colitis (ASUC) is made.

Arrange the following steps in the standard evidence-based chronological sequence for the therapeutic management and monitoring of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The standard sequence is: rule out infections and start IV steroids, monitor closely for acute complications like toxic megacolon, formally evaluate the treatment response on days 3 to 5, escalate to medical rescue therapy if steroid-refractory, and finally de-escalate to an oral taper once clinical remission is achieved.
The standard evidence-based protocol for acute severe ulcerative colitis (ASUC) relies on a stepwise escalation and de-escalation framework centered around rigorous monitoring and treatment evaluation. It begins with ruling out superimposed infections and immediately initiating high-dose IV corticosteroids. Because ASUC carries a high short-term complication rate, intensive daily monitoring for toxic megacolon is crucial during the early stages of therapy. The hallmark of ASUC management is the mandatory treatment evaluation between hospital days 3 and 5 (using indices like the Oxford criteria, which rely on stool frequency and CRP). If the patient is determined to be steroid-refractory at this specific interval, the standard of care dictates immediate escalation to medical rescue therapy (infliximab or cyclosporine) or surgical colectomy. Finally, only after achieving clinical stability and remission, the patient is transitioned to an oral steroid taper alongside long-term maintenance therapy.

Step-by-Step Solution

1
Exclude infection and start initial induction therapy
The patient begins intravenous corticosteroid therapy safely without exacerbating a hidden infection.
Enteric infections can trigger flares and complicate immunosuppression. IV steroids remain the first-line gold standard for ASUC induction.
2
Conduct rigorous daily clinical monitoring
The patient is closely monitored for colonic dilation, systemic toxicity, and deterioration.
Patients receiving initial high-dose steroids are at the highest risk for acute complications like toxic megacolon during the first 72 hours.
3
Evaluate treatment efficacy at the required interval
The clinical trajectory is objectively assessed on hospital days 3 to 5 using markers like CRP and daily stool frequency.
Evidence-based guidelines mandate a formal assessment at 72 to 120 hours to identify non-responders and prevent the risks of prolonged, ineffective steroid exposure.
4
Escalate to rescue therapy if indicated
Rescue medical therapy (e.g., infliximab) or surgical intervention is implemented.
Failure to meet objective response criteria by day 5 signifies steroid-refractory disease, requiring immediate escalation to alter the disease course.
5
De-escalate to outpatient maintenance therapy
The patient is transitioned to oral corticosteroids with a tapering plan and a long-term maintenance drug.
After the acute flare is resolved, management shifts to maintaining remission and minimizing the adverse effects of chronic corticosteroid use.

Key Concept

The management of acute severe ulcerative colitis follows a highly structured sequence: initial IV corticosteroids, rigorous complication monitoring, mandatory objective response evaluation between days 3 and 5, escalation to rescue therapy if refractory, and eventual transition to an oral taper for maintenance.
Question 540Question →

A 6868-year-old woman is brought to the emergency department from a skilled nursing facility due to altered mental status and fever. Her temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure is 74/42 mm Hg74/42\text{ mm Hg}, pulse is 128/min128/\text{min}, and respiratory rate is 24/min24/\text{min}. Oxygen saturation is 94%94\% on room air. Physical examination reveals dry mucous membranes and cloudy, malodorous urine in her Foley catheter. Laboratory studies show a leukocyte count of 18,500/mm318,500/\text{mm}^3 and a serum lactate level of 6.2 mmol/L6.2\text{ mmol/L}. Blood and urine cultures are obtained, and broad-spectrum intravenous antibiotics are initiated.

Assuming the patient's hemodynamic instability persists despite each consecutive intervention, arrange the following therapies in the correct guideline-concordant sequence for the escalating management of her septic shock.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for escalating pharmacologic therapy in septic shock is: 1) Intravenous rapid crystalloid bolus, 2) Continuous intravenous norepinephrine infusion, 3) Continuous intravenous vasopressin infusion, 4) Intravenous hydrocortisone.
The standard protocol for escalating hemodynamic support in septic shock involves a highly specific sequence designed to optimize perfusion while minimizing drug toxicity. After securing source control and administering broad-spectrum antibiotics, hemodynamic resuscitation must always begin with a rapid fluid bolus of 30 mL/kg30\text{ mL/kg} of crystalloids. This corrects the relative hypovolemia induced by systemic inflammatory vasodilation. If the mean arterial pressure (MAP) fails to stabilize at ≥65 mm Hg\geq 65\text{ mm Hg} after adequate volume expansion, continuous intravenous norepinephrine is established as the first-line vasopressor. If hypotension persists despite escalating doses of norepinephrine, vasopressin is added as a second-line agent; this capitalizes on an alternative receptor pathway (V1V_1 receptors) to augment MAP while sparing the patient from the profound ischemic and arrhythmogenic side effects of high-dose catecholamines. Finally, if the patient remains hemodynamically unstable despite adequate fluids and dual vasopressor therapy, intravenous hydrocortisone is administered to treat potential relative adrenal insufficiency and upregulate vascular adrenergic receptors.

Step-by-Step Solution

1
Recognize septic shock and initiate fluid resuscitation.
Administer 30 mL/kg of intravenous balanced crystalloids.
Hypovolemia resulting from profound vasodilation and capillary leak must be corrected first to optimize cardiac preload before utilizing vasoactive agents.
2
Assess hemodynamic response to fluids; if mean arterial pressure (MAP) remains below 65 mm Hg, start a first-line vasopressor.
Initiate continuous intravenous norepinephrine.
Norepinephrine is the vasopressor of choice in septic shock due to its strong alpha-1 agonist properties, effectively increasing systemic vascular resistance with modest beta-1 inotropic support.
3
Evaluate response to primary vasopressor therapy; if MAP remains inadequate or high doses are required, escalate with a second-line pressor.
Add continuous intravenous vasopressin.
Relative vasopressin deficiency can occur in severe sepsis. Adding vasopressin helps achieve target blood pressure while simultaneously providing a catecholamine-sparing effect to reduce norepinephrine toxicity.
4
Identify refractory shock requiring multiple or escalating vasopressors.
Administer intravenous hydrocortisone.
Corticosteroids address critical illness-related corticosteroid insufficiency (CIRCI) and sensitize the vasculature to endogenous and exogenous catecholamines. They are reserved for fluid- and vasopressor-refractory shock.

Key Concept

The management of septic shock follows a strict algorithmic escalation: adequate volume resuscitation with crystalloids, followed by norepinephrine as the first-line vasopressor, the addition of vasopressin for refractory hypotension or catecholamine-sparing, and finally intravenous corticosteroids for persistent vasopressor-refractory shock.
PreviousPage 27 / 39Next
All practice questions — USMLE Step 3 | Examkin